HealthEquity, Inc. (NASDAQ:HQY) has received an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $49.75.

A number of analysts have commented on the stock. Cantor Fitzgerald boosted their price target on shares of HealthEquity from $55.00 to $56.00 and gave the company an “overweight” rating in a research note on Wednesday. CIBC assumed coverage on shares of HealthEquity in a research note on Tuesday, March 14th. They set an “outperform” rating for the company. FIX assumed coverage on shares of HealthEquity in a research note on Tuesday, March 14th. They set an “outperform” rating for the company. Oppenheimer Holdings, Inc. assumed coverage on shares of HealthEquity in a research note on Monday, March 13th. They set an “outperform” rating and a $58.00 price target for the company. Finally, Chardan Capital boosted their price target on shares of HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, June 7th.

TRADEMARK VIOLATION NOTICE: This report was reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/07/07/healthequity-inc-hqy-given-average-rating-of-buy-by-analysts.html.

HealthEquity (NASDAQ HQY) opened at 48.30 on Friday. HealthEquity has a one year low of $27.45 and a one year high of $54.95. The firm has a market cap of $2.90 billion, a PE ratio of 90.79 and a beta of 1.79. The company’s 50-day moving average is $48.61 and its 200 day moving average is $45.03.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.03. The business had revenue of $55.40 million during the quarter, compared to analyst estimates of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. HealthEquity’s quarterly revenue was up 25.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.15 EPS. Equities analysts anticipate that HealthEquity will post $0.58 earnings per share for the current year.

In related news, VP Darcy G. Mott sold 10,000 shares of the business’s stock in a transaction dated Thursday, April 20th. The shares were sold at an average price of $43.44, for a total value of $434,400.00. Following the transaction, the vice president now directly owns 82,000 shares of the company’s stock, valued at approximately $3,562,080. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Berkley Capital, Llc sold 56,067 shares of the business’s stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $51.79, for a total transaction of $2,903,709.93. The disclosure for this sale can be found here. Insiders have sold a total of 986,916 shares of company stock worth $50,916,401 over the last ninety days. Insiders own 29.00% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Fifth Third Bancorp increased its stake in HealthEquity by 382.8% in the first quarter. Fifth Third Bancorp now owns 2,414 shares of the company’s stock valued at $102,000 after buying an additional 1,914 shares during the period. Oppenheimer Asset Management Inc. acquired a new stake in HealthEquity during the first quarter valued at approximately $106,000. Arcadia Investment Management Corp MI increased its stake in HealthEquity by 81.7% in the first quarter. Arcadia Investment Management Corp MI now owns 2,515 shares of the company’s stock valued at $107,000 after buying an additional 1,131 shares during the period. Ameritas Investment Partners Inc. acquired a new stake in HealthEquity during the first quarter valued at approximately $158,000. Finally, State of Alaska Department of Revenue increased its stake in HealthEquity by 4.3% in the first quarter. State of Alaska Department of Revenue now owns 4,850 shares of the company’s stock valued at $205,000 after buying an additional 200 shares during the period. 91.92% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.